Aberdeen Closed-End Funds: When an 11–18% 'Yield' Is Your Own Money Returned

You are scanning closed-end funds for yield in a world where cash barely clears inflation, and you see the same kind of number everywhere: a fund that pays out 11%, another at 18%. Aberdeen runs a lineup of these vehicles, and on August 11, 2026, it issued one of its routine press releases telling holders what the next checks would be. Nothing about it screams. Sandwiched between the per-share amounts, though, is a table that tells you something most investors will miss: several of the fattest "yields" in the group are not income at all.

What a closed-end fund "distribution" actually is

Quick reset for anyone new to the structure. A closed-end fund is a pool of securities that trades on an exchange like a stock, but with a fixed number of shares. Because supply is finite, its price floats above or below the value of what it owns — a premium or a discount to net asset value. To keep a steady check coming to holders, many of these funds run a "managed distribution policy": management targets a fixed amount per share and pays it out, period.

That is the mechanism that makes the August release worth reading carefully. The policy doesn't ask what the portfolio earned. It asks what the target is, and then it finds the money.

The tell in the fine print

Aberdeen's announcement listed 16 funds and their payouts, with record and ex-dividend dates of August 24 and payments on August 31 (or September 30 for a second group). For seven of them — ASGI, HQH, HQL, IAF, IFN, THQ, and THW — the release gave the tax breakdown of where each distribution comes from, under a rule known as Section 19 of the 1940 Act. That breakdown is the whole story.

Look at the healthcare funds. HQH (abrdn Healthcare Investors) declared a $0.66 payout. Its source breakdown: 0% from net investment income, 78% from realized short-term gains, 22% from realized long-term gains. HQL (abrdn Life Sciences Investors) declared $0.62 — 0% net investment income, 96% from realized short-term gains. THQ (abrdn Healthcare Opportunities) declared $0.18, also 0% from income, with 14% return of capital.

These are not income funds. They are equity-growth funds — biotech and healthcare companies that pay little in dividends — asked to hand out a stable check. To do it, they sell holdings and pass the realized gains to you. When even that isn't enough, they give back your own paid-in capital. IFN (The India Fund) declared $0.37 with a 10% return of capital; IAF (abrdn Australia Equity Fund) paid 16% of its $0.35 from return of capital.

Now the headline yields make more sense. On a trailing-twelve-month basis, HQH shows an 11% dividend yield; ASGI 11.3%; THQ 11.4%; IFN 18.3%. The reason those forward yields drop so sharply — THQ to roughly 3.8%, ASGI to roughly 3.8% — is that the capital-gains and return-of-capital portion is not repeatable income. The trailing yield counts it as if it were.

A coupon, or a withdrawal?

Here is the distinction that decides whether any of this is for you. When an operating company like, say, an energy producer or an industrial pays a dividend, it comes out of free cash flow — money the business regenerates every quarter from selling real things at prices it can defend. That is the pricing-power discipline: the payout survives because the cash flow keeps coming back.

A managed-distribution fund on these terms is the opposite. The "dividend" is a withdrawal target, not an earnings result. When 78% of your check is realized capital gains, the fund is converting your own unrealized appreciation into cash for you. When 14% is return of capital, you are literally being handed back principal, and the fund's net asset value shrinks by that amount as it goes. This is honest disclosure — the Section 19 notice exists precisely to show you where the money came from — but it is the opposite of a coupon. It is a retirement withdrawal wearing a dividend's clothes.

None of this makes the vehicles "bad" in an absolute sense. Some shareholders are legitimately harvesting gains and capital to fund retirement, and a steady check can be emotionally and practically useful. But it changes the entire investment case. The yield you are paid is partly a return of the very principal you bought the fund to preserve, and the distribution continues only as long as the portfolio has gains to realize or capital to return.

What to do before you buy on yield

The practical takeaway is not "avoid closed-end funds." It is: never buy one on the headline yield, because the headline does not tell you what you are being paid with. Read the Section 19 notice. It answers the one question that matters — how much of this is actual earned income, and how much is the fund liquidating itself to pay you.

Sort the Aberdeen lineup into the two groups the release itself creates. The managed-distribution funds — the healthcare, infrastructure, India and Australia equity portfolios paying 0% net investment income — are withdrawal vehicles. The others paying routine income from bond and dividend portfolios are closer to true income funds. And if you hold the September group, know that HQH, HQL, IAF, IFN, THQ and THW pay those distributions in newly issued shares by default unless you elect cash by mid-September — fine for reinvestment, but a reminder that you are receiving new shares, not guaranteed cash.

I don't think investors are being paid to chase the highest current yield anywhere, and that is doubly true here. In a world where inflation keeps grinding, the real test of an income stream is whether the thing producing it can keep earning and re-earning it — a company's free cash flow, not a distribution policy's target. An 18% yield funded by your own capital is not an income shortcut. It is a slow sale of the asset, dressed up in a press release every month.